Bioorganic & Medicinal Chemistry 2004-09-01

Tumor promoter binding of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s.

Kazuhiro Irie, Akiko Masuda, Mayumi Shindo, Yu Nakagawa, Hajime Ohigashi

Index: Bioorg. Med. Chem. 12(17) , 4575-83, (2004)

Full Text: HTML

Abstract

Recent investigations discovered nonkinase-type phorbol ester receptors, RasGRPs, chimaerins, and Unc13s. Phorbol ester binding occurs at the cysteine-rich sequences of about 50 residues in the C1 domains of these receptors. Fifty-one-residue RasGRP C1 peptides except for RasGRP2 showed significant phorbol 12,13-dibutyrate (PDBu) binding, but the K(d) values of the RasGRP1 and RasGRP3 C1 peptides were about 10-fold larger than those for the corresponding whole enzymes. Addition of the C-terminal basic amino acid cluster decreased their K(d) values about 10-fold, suggesting that the positive charges of these C1 peptides play an important role in the PDBu binding in the presence of negatively-charged phosphatidylserine. The 51-mer chimaerin C1 peptides showed potent PDBu binding, while the Unc13 and Munc13-1 C1 peptides without sufficient positive charges hardly bound PDBu. By the rapid screening system using this C1 peptide library, 5-prenyl-indolactam-V was identified as a promising lead for the novel protein kinase C isozyme specific ligands.


Related Compounds

Related Articles:

Structural basis of RasGRP binding to high-affinity PKC ligands.

2002-02-14

[J. Med. Chem. 45(4) , 853-60, (2002)]

Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.

2004-01-01

[Curr. Pharm. Des. 10(12) , 1371-85, (2004)]

Binding selectivity of conformationally restricted analogues of (-)-indolactam-V to the C1 domains of protein kinase C isozymes.

2002-07-01

[Biosci. Biotechnol. Biochem. 66(7) , 1615-7, (2002)]

Protein kinase signalling requirements for metabotropic action of kainate receptors in rat CA1 pyramidal neurones.

2007-03-01

[J. Physiol. 579(Pt 2) , 363-73, (2007)]

Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts.

2014-10-01

[Mol. Pharmacol. 86(4) , 406-16, (2014)]

More Articles...